The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models
Open accessAbstract
Patient-derived xenograft (PDX) models are created by engraftment of patient tumor tissues into immunocompetent mice. Since a PDX model retains the characteristics of the primary patient tumor including gene expression profiles and drug responses, it has become the most reliable in vivo human cancer model. The engraftment rate increases with the introduction of Non-obese diabetic Severe combined immunodeficiency (NOD/SCID)-based immunocompromised mice, especially the NK-deficient NOD strains NOD/SCID/interleukin-2 receptor gamma chain(IL2Rγ)null (NOG/NSG) and NOD/SCID/Jak3(Janus kinase 3)null (NOJ). Success rates differ with tumor origin: gastrointestinal tumors acquire a higher engraftment rate, while the rate is lower for breast cancers. Subcutaneous transplantation is the most popular method to establish PDX, but some tumors require specific environments, e.g., orthotropic or renal capsule transplantation. Human hormone treatment is necessary to establish hormone-dependent cancers such as prostate and breast cancers. PDX mice with human hematopoietic and immune systems (humanized PDX) are powerful tools for the analysis of tumor–immune system interaction and evaluation of immunotherapy response. A PDX biobank equipped with patients’ clinical data, gene-expression patterns, mutational statuses, tumor tissue architects, and drug responsiveness will be an authoritative resource for developing specific tumor biomarkers for chemotherapeutic predictions, creating individualized therapy, and establishing precise cancer medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822
A severe combined immunodeficiency mutation in the mouse
Bosma, G. C., Custer, R. P., & Bosma, M. J. (1983) · Nature · doi:10.1038/301527a0 · Cited by 2,207
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Hidalgo, M., Amant, F., Biankin, A. V., Budinská, E., Byrne, A. T., Caldas, C., Clarke, R. B., de Jong, S., Jonkers, J., Mælandsmo, G. M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0001 · Cited by 1,742
Shultz, L. D., Lyons, B. L., Burzenski, L. M., Gott, B., Chen, X., Chaleff, S., Kotb, M., Gillies, S. D., King, M., Mangada, J., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6477 · Cited by 1,728
NOD/SCID/γcnull mouse: an excellent recipient mouse model for engraftment of human cells
Ito, M., Hiramatsu, H., Kobayashi, K., Suzue, K., Kawahata, M., Hioki, K., Ueyama, Y., Koyanagi, Y., Sugamura, K., Tsuji, K., et al. (2002) · Blood · doi:10.1182/blood-2001-12-0207 · Cited by 1,476
McCune, J., Namikawa, R., Kaneshima, H., Shultz, L., Lieberman, M., & Weissman, I. (1988) · Science · doi:10.1126/science.241.4873.1632 · Cited by 1,406
Gao, H., Korn, J. M., Ferretti, S., Monahan, J. E., Wang, Y., Singh, M., Zhang, C., Schnell, C., Yang, G., Zhang, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3954 · Cited by 1,393
Humanized mice in translational biomedical research
Shultz, L. D., Ishikawa, F., & Greiner, D. L. (2007) · Nature Reviews Immunology · doi:10.1038/nri2017 · Cited by 1,279
Patient-derived tumour xenografts as models for oncology drug development
Tentler, J. J., Tan, A. C., Weekes, C. D., Jimeno, A., Leong, S., Pitts, T. M., Arcaroli, J. J., Messersmith, W. A., & Eckhardt, S. G. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.61 · Cited by 1,277
Transfer of a functional human immune system to mice with severe combined immunodeficiency
Mosier, D. E., Gulizia, R. J., Baird, S. M., & Wilson, D. B. (1988) · Nature · doi:10.1038/335256a0 · Cited by 1,255
Breeding of a Non-Obese, Diabetic Strain of Mice
MAKINO, S., KUNIMOTO, K., MURAOKA, Y., MIZUSHIMA, Y., KATAGIRI, K., & TOCHINO, Y. (1980) · Experimental Animals · doi:10.1538/expanim1978.29.1_1 · Cited by 1,249
Multiple defects in innate and adaptive immunologic function in NOD/LtSz- scid mice.
Shultz, L. D., Schweitzer, P. A., Christianson, S. W., Gott, B., Schweitzer, I. B., Tennent, B., McKenna, S., Mobraaten, L., Rajan, T. V., Greiner, D. L., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.180 · Cited by 1,223
Humanized mice in translational biomedical research
Shultz, L. (2007) · The Mouseion at the JAXlibrary (Jackson Laboratory) · Cited by 1,036
DeRose, Y. S., Wang, G., Lin, Y.-C., Bernard, P. S., Buys, S. S., Ebbert, M. T. W., Factor, R., Matsen, C., Milash, B. A., Nelson, E., et al. (2011) · Nature Medicine · doi:10.1038/nm.2454 · Cited by 1,002
Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice
Traggiai, E., Chicha, L., Mazzucchelli, L., Bronz, L., Piffaretti, J.-C., Lanzavecchia, A., & Manz, M. G. (2004) · Science · doi:10.1126/science.1093933 · Cited by 993
Bertotti, A., Migliardi, G., Galimi, F., Sassi, F., Torti, D., Isella, C., Corà, D., Di Nicolantonio, F., Buscarino, M., Petti, C., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0109 · Cited by 939
‘Nude’, a new hairless gene with pleiotropic effects in the mouse
Flanagan, S. P. (1966) · Genetical Research · doi:10.1017/s0016672300010168 · Cited by 869
Patient-derived xenografts undergo mouse-specific tumor evolution
Ben-David, U., Ha, G., Tseng, Y.-Y., Greenwald, N. F., Oh, C., Shih, J., McFarland, J. M., Wong, B., Boehm, J. S., Beroukhim, R., et al. (2017) · Nature Genetics · doi:10.1038/ng.3967 · Cited by 716
Interrogating open issues in cancer precision medicine with patient-derived xenografts
Byrne, A. T., Alférez, D. G., Amant, F., Annibali, D., Arribas, J., Biankin, A. V., Bruna, A., Budinská, E., Caldas, C., Chang, D. K., et al. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.140 · Cited by 657
Immunotherapy: past, present and future
Waldmann, T. A. (2003) · Nature Medicine · doi:10.1038/nm0303-269 · Cited by 628
Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells
Takenaka, K., Prasolava, T. K., Wang, J. C. Y., Mortin-Toth, S. M., Khalouei, S., Gan, O. I., Dick, J. E., & Danska, J. S. (2007) · Nature Immunology · doi:10.1038/ni1527 · Cited by 509
The Murine Autoimmune Diabetes Model: NOD and Related Strains
Kikutani, H., & Makino, S. (1992) · Advances in Immunology · doi:10.1016/s0065-2776(08)60490-3 · Cited by 496
Zhang, X., Claerhout, S., Prat, A., Dobrolecki, L. E., Petrovic, I., Lai, Q., Landis, M. D., Wiechmann, L., Schiff, R., Giuliano, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4081 · Cited by 481
Lan, P., Tonomura, N., Shimizu, A., Wang, S., & Yang, Y.-G. (2006) · Blood · doi:10.1182/blood-2005-11-4388 · Cited by 478
The beige mutation in the mouse selectively impairs natural killer cell function
Roder, J., & Duwe, A. K. (1979) · Nature · doi:10.1038/278451a0 · Cited by 460
Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts
Hoffman, R. M. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3972 · Cited by 425
A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays
Marangoni, E., Vincent-Salomon, A., Auger, N., Degeorges, A., Assayag, F., de Cremoux, P., de Plater, L., Guyader, C., De Pinieux, G., Judde, J.-G., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0078 · Cited by 422
Xenograft and organoid model systems in cancer research
Bleijs, M., van de Wetering, M., Clevers, H., & Drost, J. (2019) · The EMBO Journal · doi:10.15252/embj.2019101654 · Cited by 400
Shultz, L. D., Saito, Y., Najima, Y., Tanaka, S., Ochi, T., Tomizawa, M., Doi, T., Sone, A., Suzuki, N., Fujiwara, H., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000475107 · Cited by 366
Julien, S., Merino-Trigo, A., Lacroix, L., Pocard, M., Goéré, D., Mariani, P., Landron, S., Bigot, L., Nemati, F., Dartigues, P., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0372 · Cited by 360
Examining the utility of patient-derived xenograft mouse models
Aparicio, S., Hidalgo, M., & Kung, A. L. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3944 · Cited by 345
Current status and future directions of cancer immunotherapy
Zhang, H., & Chen, J. (2018) · Journal of Cancer · doi:10.7150/jca.24577 · Cited by 345
Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts
Cassidy, J. W., Caldas, C., & Bruna, A. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0727 · Cited by 343
Billerbeck, E., Barry, W. T., Mu, K., Dorner, M., Rice, C. M., & Ploss, A. (2011) · Blood · doi:10.1182/blood-2010-08-301507 · Cited by 304
Current status and perspectives of patient-derived xenograft models in cancer research
Lai, Y., Wei, X., Lin, S., Qin, L., Cheng, L., & Li, P. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0470-7 · Cited by 295
Humanized Mice for the Study of Immuno-Oncology
De La Rochere, P., Guil-Luna, S., Decaudin, D., Azar, G., Sidhu, S. S., & Piaggio, E. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.07.001 · Cited by 291
Fichtner, I., Rolff, J., Soong, R., Hoffmann, J., Hammer, S., Sommer, A., Becker, M., & Merk, J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0138 · Cited by 286
Comparison of human cord blood engraftment between immunocompromised mouse strains
McDermott, S. P., Eppert, K., Lechman, E. R., Doedens, M., & Dick, J. E. (2010) · Blood · doi:10.1182/blood-2010-02-271841 · Cited by 284
The hairless mouse in skin research
Benavides, F., Oberyszyn, T. M., VanBuskirk, A. M., Reeve, V. E., & Kusewitt, D. F. (2009) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2008.08.012 · Cited by 283
Patient-derived xenograft models of breast cancer and their predictive power
Whittle, J. R., Lewis, M. T., Lindeman, G. J., & Visvader, J. E. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0523-1 · Cited by 282
Garrido-Laguna, I., Uson, M., Rajeshkumar, N. V., Tan, A. C., de Oliveira, E., Karikari, C., Villaroel, M. C., Salomon, A., Taylor, G., Sharma, R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0341 · Cited by 247
Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models
Hoffman, R. M. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00848-3 · Cited by 240
Humanized Mouse Xenograft Models: Narrowing the Tumor–Microenvironment Gap
Morton, J. J., Bird, G., Refaeli, Y., & Jimeno, A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1260 · Cited by 237
Strowig, T., Rongvaux, A., Rathinam, C., Takizawa, H., Borsotti, C., Philbrick, W., Eynon, E. E., Manz, M. G., & Flavell, R. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109769108 · Cited by 228
Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review
Jin, K., Teng, L., Shen, Y., He, K., Xu, Z., & Li, G. (2010) · Clinical and Translational Oncology · doi:10.1007/s12094-010-0540-6 · Cited by 217
Human Cancer Growth and Therapy in Immunodeficient Mouse Models
Shultz, L. D., Goodwin, N., Ishikawa, F., Hosur, V., Lyons, B. L., & Greiner, D. L. (2014) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top073585 · Cited by 212
Clinical Approval Success Rates for Investigational Cancer Drugs
DiMasi, J. A., Reichert, J. M., Feldman, L., & Malins, A. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.117 · Cited by 203
Zhao, Y., Shuen, T. W. H., Toh, T. B., Chan, X. Y., Liu, M., Tan, S. Y., Fan, Y., Yang, H., Lyer, S. G., Bonney, G. K., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315201 · Cited by 200
A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma
Sivanand, S., Peña-Llopis, S., Zhao, H., Kucejova, B., Spence, P., Pavia-Jimenez, A., Yamasaki, T., McBride, D. J., Gillen, J., Wolff, N. C., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003643 · Cited by 193
Tumorgrafts as In Vivo Surrogates for Women with Ovarian Cancer
Weroha, S. J., Becker, M. A., Enderica-Gonzalez, S., Harrington, S. C., Oberg, A. L., Maurer, M. J., Perkins, S. E., AlHilli, M., Butler, K. A., McKinstry, S., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2611 · Cited by 189
Dong, X., Guan, J., English, J. C., Flint, J., Yee, J., Evans, K., Murray, N., MacAulay, C., Ng, R. T., Gout, P. W., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2878 · Cited by 188
Wang, Y., Revelo, M. P., Sudilovsky, D., Cao, M., Chen, W. G., Goetz, L., Xue, H., Sadar, M., Shappell, S. B., Cunha, G. R., et al. (2005) · The Prostate · doi:10.1002/pros.20225 · Cited by 179
A biobank of patient-derived pediatric brain tumor models
Brabetz, S., Leary, S. E. S., Gröbner, S. N., Nakamoto, M. W., Şeker-Cin, H., Girard, E. J., Cole, B., Strand, A. D., Bloom, K. L., Hovestadt, V., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0207-3 · Cited by 176
Humanized hemato-lymphoid system mice
Theocharides, A. P. A., Rongvaux, A., Fritsch, K., Flavell, R. A., & Manz, M. G. (2016) · Haematologica · doi:10.3324/haematol.2014.115212 · Cited by 166
Patient-derived xenografts: a relevant preclinical model for drug development
Pompili, L., Porru, M., Caruso, C., Biroccio, A., & Leonetti, C. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0462-4 · Cited by 161
Keysar, S. B., Astling, D. P., Anderson, R. T., Vogler, B. W., Bowles, D. W., Morton, J. J., Paylor, J. J., Glogowska, M. J., Le, P. N., Eagles-Soukup, J. R., et al. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.03.004 · Cited by 160
A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma
Krepler, C., Sproesser, K., Brafford, P. A., Beqiri, M., Garman, B., Xiao, M., Shannan, B., Watters, A. K., Perego, M., Zhang, G., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.021 · Cited by 157
An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
Cho, S., Kang, W., Han, J. Y., Min, S., Kang, J., Lee, A., Kwon, J. Y., Lee, C., & Park, H. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.2350 · Cited by 155
Topp, M. D., Hartley, L., Cook, M., Heong, V. Y. M., Boehm, E., McShane, L., Pyman, J. M., McNally, O., Ananda, S. S., Harrell, M., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.01.008 · Cited by 145
Patient-Derived Xenograft Models of Breast Cancer and Their Application
Murayama, T., & Gotoh, N. (2019) · Cells · doi:10.3390/cells8060621 · Cited by 145
Yamauchi, T., Takenaka, K., Urata, S., Shima, T., Kikushige, Y., Tokuyama, T., Iwamoto, C., Nishihara, M., Iwasaki, H., Miyamoto, T., et al. (2013) · Blood · doi:10.1182/blood-2012-06-440354 · Cited by 143
US cancer institute to overhaul tumour cell lines
Ledford, H. K. (2016) · Nature · doi:10.1038/nature.2016.19364 · Cited by 143
Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice
Choi, Y., Lee, S., Kim, K., Kim, S. H., Chung, Y., & Lee, C. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0115-0 · Cited by 139
Suzuki, K., Nakajima, H., Saito, Y., Saito, T., Leonard, W. J., & Iwamoto, I. (2000) · International Immunology · doi:10.1093/intimm/12.2.123 · Cited by 138
Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
Ricci, F., Bizzaro, F., Cesca, M., Guffanti, F., Ganzinelli, M., Decio, A., Ghilardi, C., Perego, P., Fruscio, R., Buda, A. A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0274 · Cited by 135
Yang, M., Reynoso, J., Jiang, P., Li, L., Moossa, A. R., & Hoffman, R. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-3118 · Cited by 134
A patient‐derived explant ( PDE ) model of hormone‐dependent cancer
Centenera, M. M., Hickey, T. E., Jindal, S., Ryan, N. K., Ravindranathan, P., Mohammed, H., Robinson, J. L. L., Schiewer, M. J., Ma, S., Kapur, P., et al. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12354 · Cited by 130
Dobbin, Z. C., Katre, A. A., Steg, A. D., Erickson, B. K., Shah, M. M., Alvarez, R. D., Conner, M., Schneider, D. A., Chen, D., & Landen, C. N. (2014) · Oncotarget · doi:10.18632/oncotarget.2373 · Cited by 120
Choi, Y. Y., Lee, J. E., Kim, H., Sim, M. H., Kim, K.-K., Lee, G., Kim, H., An, J. Y., Hyung, W. J., Kim, C. B., et al. (2016) · Scientific Reports · doi:10.1038/srep22172 · Cited by 115
Kimple, R. J., Harari, P. M., Torres, A. D., Yang, R., Soriano, B. J., Yu, M., Armstrong, E. A., Blitzer, G. C., Smith, M. A., Lorenz, L. D., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2746 · Cited by 110
Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts
Cottu, P. H., Marangoni, E., Assayag, F., de Crémoux, P., Vincent‐Salomon, A., Guyader, C., de Plater, L., Ganem‐Elbaz, C., Karboul, N., Fontaine, J. J., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1815-5 · Cited by 105
Notarangelo, L. D., Giliani, S., Mazza, C., Mella, P., Savoldi, G., Rodriguez‐Pérez, C., Mazzolari, E., Fiorini, M., Duse, M., Plebani, A., et al. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17812.x · Cited by 102
Mattie, M., Christensen, A., Chang, M. S., Yeh, W., Said, S., Shostak, Y., Capo, L., Verlinsky, A., An, Z., Joseph, I. B. J., et al. (2013) · Neoplasia · doi:10.1593/neo.13922 · Cited by 100
Patient‑derived xenograft mouse models: A high fidelity tool for individualized medicine (Review)
Xu, C., Li, X., Liu, P., Li, M., & Luo, F. (2018) · Oncology Letters · doi:10.3892/ol.2018.9583 · Cited by 94
Modeling Tumor Immunology and Immunotherapy in Mice
Buqué, A., & Galluzzi, L. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.07.003 · Cited by 91
Ono, A., Hattori, S.-I., Kariya, R., et al. (2011) · BioMed Research International · doi:10.1155/2011/539748 · Cited by 90
Self-citationWang, D. Y. Q., Pham, N., Tong, J., Sakashita, S., Allo, G., Kim, L., Yanagawa, N., Raghavan, V., Wei, Y., To, C., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30472 · Cited by 89
Okada, S., Harada, H., Ito, T., Saito, T., & Suzu, S. (2008) · International Journal of Hematology · doi:10.1007/s12185-008-0215-z · Cited by 80
Self-citationEinarsdottir, B. O., Bagge, R. O., Bhadury, J., Jespersen, H., Mattsson, J., Nilsson, L. M., Truvé, K., López, M. D., Naredi, P. L. J., Nilsson, O., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2445 · Cited by 78
Collins, A. T., & Lang, S. (2018) · PeerJ · doi:10.7717/peerj.5981 · Cited by 76
Zhu, Y., Tian, T., Li, Z., Tang, Z., Wang, L., Wu, J., Li, Y., Dong, B., Li, Y., Li, N., et al. (2015) · Scientific Reports · doi:10.1038/srep08542 · Cited by 75
Okada, S., Vaeteewoottacharn, K., & Kariya, R. (2018) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c17-00789 · Cited by 75
Self-citationPatient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
Heo, E. J., Cho, Y., Cho, W. C. S., Hong, J. E., Jeon, H., Oh, D., Choi, Y., Song, S. Y., Choi, J., Bae, D., et al. (2017) · Cancer Research and Treatment · doi:10.4143/crt.2016.322 · Cited by 74
Mosier, D. E., Stell, K. L., Gulizia, R. J., Torbett, B. E., & Gilmore, G. L. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.1.191 · Cited by 73
Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic review
Brown, K. M., Xue, A., Mittal, A., Samra, J. S., Smith, R. C., & Hugh, T. J. (2016) · Oncotarget · doi:10.18632/oncotarget.11184 · Cited by 70
Creation of PDX-Bearing Humanized Mice to Study Immuno-oncology
Yao, L., Aryee, K., Cheng, M., Kaur, P., Keck, J., & Brehm, M. A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9145-7_15 · Cited by 69
Crottès, D., Rapetti‐Mauss, R., Alcaraz‐Pérez, F., Tichet, M., Gariano, G., Martial, S., Guizouarn, H., Pellissier, B., Loubat, A., Popa, A., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1465 · Cited by 68
Establishment and Genomic Characterization of Mouse Xenografts of Human Primary Prostate Tumors
Priolo, C., Agostini, M., Vena, N., Ligon, A. H., Fiorentino, M., Shin, E., Farsetti, A., Pontecorvi, A., Sicińska, E., & Loda, M. F. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090873 · Cited by 64
Establishment of patient-derived cancer xenografts in immunodeficient NOG mice
Chijiwa, T., Kawai, K., NOGUCHI, A., Sato, H., Hayashi, A., Cho, H., Shiozawa, M., Kishida, T., Morinaga, S., Yokose, T., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2997 · Cited by 60
A novel eGFP‐expressing immunodeficient mouse model to study tumor‐host interactions
Niclou, S. P., Danzeisen, C., Eikesdal, H. P., Wiig, H., Brons, N. H. C., Poli, A., Engelsen, A. S. T., Torsvik, A., Enger, P. Ø., Terzis, J. A., et al. (2008) · The FASEB Journal · doi:10.1096/fj.08-109611 · Cited by 60
Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines
Oyama, R., Takahashi, M., Yoshida, A., Sakumoto, M., Takai, Y., Kito, F., Shiozawa, K., Qiao, Z., Arai, Y., Shibata, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04967-0 · Cited by 60
CD47: a new player in phagocytosis and xenograft rejection
Navarro–Álvarez, N., & Yang, Y. (2011) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.83 · Cited by 57
Next-Generation in vivo Modeling of Human Cancers
Gargiulo, G. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00429 · Cited by 57
Goto, H., Kojima, Y., Matsuda, K., Kariya, R., Taura, M., Kuwahara, K., Nagai, H., Katano, H., & Okada, S. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.03.004 · Cited by 51
Self-citationBe open about drug failures to speed up research
Alteri, E., & Guizzaro, L. (2018) · Nature · doi:10.1038/d41586-018-07352-7 · Cited by 50
Vaeteewoottacharn, K., Pairojkul, C., Kariya, R., Muisuk, K., Imtawil, K., Chamgramol, Y., Bhudhisawasdi, V., Khuntikeo, N., Pugkhem, A., Saeseow, O.-T., et al. (2019) · Cells · doi:10.3390/cells8050496 · Cited by 47
Self-citationA novel therapeutic molecule against HTLV-1 infection targeting provirus
Tanaka, A., Takeda, S., Kariya, R., Matsuda, K., Urano, E., Okada, S., & Komano, J. (2013) · Leukemia · doi:10.1038/leu.2013.46 · Cited by 46
Self-citationInhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma
Vaeteewoottacharn, K., Kariya, R., Dana, P., Fujikawa, S., Matsuda, K., Ohkuma, K., Kudo, E., Kraiklang, R., Wongkham, C., Wongkham, S., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-4785-8 · Cited by 45
Self-citationLiu, Y., Chanana, P., Davila, J. I., Hou, X., Zanfagnin, V., McGehee, C. D., Goode, E. L., Polley, E. C., Haluska, P., Weroha, S. J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42680-2 · Cited by 45
Iwamoto, C., Takenaka, K., Urata, S., Yamauchi, T., Shima, T., Kuriyama, T., Daitoku, S., Saito, Y., Miyamoto, T., Iwasaki, H., et al. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.11.005 · Cited by 43
Wang, H., Lu, J., Wang, L., Chen, S., He, K., Jiang, X., Jiang, W., & Teng, L. (2017) · BMC Cancer · doi:10.1186/s12885-017-3177-9 · Cited by 43
Cavalloni, G., Neia, C. P., Sassi, F. P., Chiorino, G., Sarotto, I., Aglietta, M., & Leone, F. (2016) · BMC Cancer · doi:10.1186/s12885-016-2136-1 · Cited by 42
Chen, Y., Zhang, R., Wang, L., Correa, A. M., Pataer, A., Xu, Y., Zhang, X., Ren, C., Wu, S., Meng, Q. H., et al. (2019) · Cancer · doi:10.1002/cncr.32366 · Cited by 42
Zeng, Y. C., Liu, B., Rubio, M., Wang, X., Ojcius, D. M., Tang, R., Dürrbach, A., Ru, Z., Zhou, Y., & Lone, Y. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173754 · Cited by 40
Generation of stable PDX derived cell lines using conditional reprogramming
Borodovsky, A., McQuiston, T. J., Stetson, D., Ahmed, A., Whitston, D., Zhang, J., Grondine, M. R., Lawson, D., Challberg, S. S., Zinda, M. J., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0745-1 · Cited by 40
Chou, J., Fitzgibbon, M., Mortales, C., Towlerton, A. M. H., Upton, M. P., Yeung, R. S. W., McIntosh, M. W., & Warren, E. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079874 · Cited by 39
Hereditary immunodeficiency and leukemogenesis in HRS-J mice.
Heiniger, H. J., Meier, H., Kaliss, N., Cherry, M., Chen, H. W., & Stoner, R. D. (1974) · PubMed · Cited by 36
Dong, Y., Manley, B. J., Becerra, M. F., Redzematovic, A., Casuscelli, J., Tennenbaum, D. M., Reznik, E., Han, S., Benfante, N. E., Chen, Y., et al. (2016) · European Urology Focus · doi:10.1016/j.euf.2016.08.005 · Cited by 36
Dependency of Cholangiocarcinoma on Cyclin D–Dependent Kinase Activity
Sittithumcharee, G., Suppramote, O., Vaeteewoottacharn, K., Sirisuksakun, C., Jamnongsong, S., Laphanuwat, P., Suntiparpluacha, M., Matha, A., Chusorn, P., Buraphat, P., et al. (2019) · Hepatology · doi:10.1002/hep.30704 · Cited by 35
Self-citationEstablishment of a large panel of patient-derived preclinical models of human renal cell carcinoma
Lang, H., Béraud, C., Béthry, A., Danilin, S., Lindner, V., Coquard, C., Rothhut, S., & Massfelder, T. (2016) · Oncotarget · doi:10.18632/oncotarget.10659 · Cited by 31
Zhang, T., Zhang, L., Fan, S., Zhang, M., Fu, H., Liu, Y., Yin, X., Chen, H., Xie, L., Zhang, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134493 · Cited by 30
Oncological and genetic factors impacting PDX model construction with NSG mice in pancreatic cancer
Guo, S., Gao, S., Liu, R., Shen, J., Shi, X., Bai, S., Wang, H., Zheng, K., Shao, Z., Liang, C., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800617r · Cited by 27
Nagatani, M., Kodera, T., Suzuki, D., Igura, S., Fukunaga, Y., Kanemitsu, H., Nakamura, D., Mochizuki, M., Kemi, M., Tamura, K., et al. (2019) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.19-0024 · Cited by 24
Kojima, Y., Hayakawa, F., Morishita, T., Sugimoto, K., Minamikawa, Y., Iwase, M., Yamamoto, H., Hirano, D., Imoto, N., Shimada, K., et al. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.04.006 · Cited by 18
Self-citationThomsen, M., Galvani, S., Canivet, C., Kamar, N., & Böhler, T. (2007) · Toxicology · doi:10.1016/j.tox.2007.10.017 · Cited by 17
Selective expansion and engraftment of human CD16+ NK cells in NOD/SCID mice
Harada, H., Suzu, S., Ito, T., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200535125 · Cited by 17
Hoffman, R. M., & Bouvet, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.12.021 · Cited by 17
Goto, H., Matsuda, K., Srikoon, P., Kariya, R., Hattori, S.-I., Taura, M., Katano, H., & Okada, S. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.12.021 · Cited by 15
Self-citationGotoh, K., Kariya, R., Matsuda, K., Hattori, S.-I., Vaeteewoottacharn, K., & Okada, S. (2014) · BioScience Trends · doi:10.5582/bst.2014.01049 · Cited by 11
Self-citationPotential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system
Shima, K., Mizuma, M., Hayashi, H., Nakagawa, K., Okada, T., Sakata, N., Omura, N., Kitamura, Y., Motoi, F., Rikiyama, T., et al. (2012) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-31-55 · Cited by 6
Goto, H., Kariya, R., Matsuda, K., Kudo, E., Katano, H., & Okada, S. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.01.011 · Cited by 4
Self-citation
Cited by
Patient-derived xenograft models in cancer therapy: technologies and applications
Liu, Y., Wu, W., Cai, C., Zhang, H., Shen, H., & Han, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01419-2 · Cited by 494
Patient-derived xenograft (PDX) models, applications and challenges in cancer research
Abdolahi, S., Ghazvinian, Z., Muhammadnejad, S., Saleh, M., Asadzadeh Aghdaei, H., & Baghaei, K. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03405-8 · Cited by 326
Yun, J., Lee, S.-H., Kim, S.-Y., Jeong, S.-Y., Kim, J.-H., Pyo, K.-H., Park, C.-W., Heo, S. G., Yun, M. R., Lim, S., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0116 · Cited by 297
Harnessing the predictive power of preclinical models for oncology drug development
Honkala, A., Malhotra, S. V., Kummar, S., & Junttila, M. R. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00301-6 · Cited by 121
Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer
Rizzo, G., Bertotti, A., Leto, S. M., & Vetrano, S. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01970-2 · Cited by 51
Metadata
- Authors
- Okada, S., Vaeteewoottacharn, K., & Kariya, R.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-08-13
- Volume
- 8
- Issue
- 8
- Pages
- 889
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W2946904796
- Cited by
- 263
- References
- 123
- FWCI
- 10.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.